专利内容由知识产权出版社提供
专利名称：METHOD AND PHARMACEUTICAL
COMPOSITION FOR INHIBITINGPI3K/AKT/MTOR SIGNAL PATH
发明人：Duan, Lei,Levenson, Viktor,Ying, Guoguang申请号：EP13841191.3申请日：20130929公开号：EP2905032A1公开日：20150812
专利附图：
摘要：The present invention relates to a pharmaceutical composition of PRCPantagonist, PREP antagonist, or PRCP-PREP dual antagonist. The present invention also
relates to a pharmaceutical composition jointly using PRCP antagonist and mTORantagonist, or jointly using PREP antagonist and mTOR antagonist, or jointly using PRCP-PREP dual antagonist and mTOR antagonist. In addition, the present invention alsorelates to a method for utilizing the pharmaceutical compositions to treat and preventcancers and diseases related to insulin receptor substrate protein and PI3K/AKT/mTORsignal pathway.
申请人：Targeted Therapeutics, LLC
地址：29 Buckingham Lane Buffalo Grove, IL 600 US
国籍：US
代理机构：Williams, Andrea
更多信息请下载全文后查看
